The IMF's April 2025 World Economic Outlook Report highlights the top 10 nations by GDP, with the United States, China, and Germany leading. These economic powerhouses offer a rich tapestry of ...
Makati City recorded the highest per capita income among the Philippines' highly-urbanized cities in 2024, posting P3.889 ...
India’s reliance on household credit has surged sharply in recent years, with new data presented in the Lok Sabha showing ...
Travelbinger on MSN
The Wealthiest State in America Isn't New York or California
When you picture the richest parts of America, your mind probably races to Manhattan penthouses or Silicon Valley tech campuses. Those images stick because they’re visible, flashy, and frankly, they ...
BirBir, one of the largest and most rapidly growing e-commerce and classifieds platforms in Uzbekistan, announces significant ...
Vancouver Sun on MSNOpinion
No society in history has improved its standard of living without low-cost energy: B.C. expert
Canada’s energy debate has suddenly flipped upside down.
Bun is a JavaScript, TypeScript, and JSX toolkit, and Anthropic plans to incorporate it into Claude Code to improve ...
13don MSN
500%, 600%, 700%! Trump claims drug prices falling at levels never seen before, without giving data
US President Donald Trump claims drug prices have dropped significantly due to favored nations status. He asserts this as a revolutionary change in healthcare without providing evidence. Meanwhile, ...
Opinion
The Chosun Ilbo on MSNOpinion
South Korea Third Most Affluent in '30·50 Club' but Faces High-Cost Challenges
In 2018, South Korea reached a benchmark symbolizing a major power. It joined the ‘30·50 club,’ a group of nations with a per capita national income exceeding $30,000 and a population of over 50 ...
By Patrick Wingrove and Deena Beasley (Reuters) -The U.S. government is expected this week to announce negotiated prices for 15 of the highest-cost prescription drugs under its Medicare health plan, a ...
Novartis executive says Europe needs faster approvals, stronger incentives, and firmer IP rules to keep cutting-edge pharma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results